🔬 Science
2d ago
PET biomarker outperforms established risk score in predicting survival for large B-cell lymphoma patients
Source ↗
👁 0
💬 0
Metabolic tumor volume—a biomarker derived from PET imaging—can more accurately predict progression-free survival for large B-cell lymphoma patients than the widely used International Prognostic Index. By identifying patients who are more likely to have poor outcomes early, the PET biomarker can contribute to the individualization of therapies, according to a study published in The Journal of Nuclear Medicine.
Comments (0)